Search results
AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect
The Telegraph via Yahoo News· 2 hours agoThe Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical...
Moderna (NASDAQ:MRNA) PT Raised to $106.00
ETF DAILY NEWS· 20 hours agoModerna (NASDAQ:MRNA – Free Report) had its price target increased by Canaccord Genuity Group from $91.00 to $106.00 in a report published on Friday, Benzinga reports. Canaccord ...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 5 days agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
Fauci, other top health officials receive Moderna Covid-19 vaccine on camera
AOL· 9 hours agoFauci, director of the National Institute of Allergy and Infectious Diseases, received the shot...
Tech Bytes: Moderna partners with OpenAI to expedite drug development processes
Proactive Investors· 16 hours agoModerna, the biotechnology firm best known for its COVID-19 vaccines, has partnered with artificial...
Check Out What Whales Are Doing With MRNA - Moderna (NASDAQ:MRNA)
Benzinga· 5 hours agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Moderna MRNA , and it's something market players shouldn't ignore. Our tracking of public ...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 1 day agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Insider Sale Alert: Moderna Inc [MRNA] – Is it Time to sell? – Knox Daily
Knox Daily· 15 hours agoIn a filing, Moderna Inc revealed its Director AFEYAN NOUBAR unloaded Company’s shares for reported $1.66 million on May 01 ’24. In the deal valued at $110.92 per share,15,000 ...
Analysts Are Updating Their Moderna, Inc. (NASDAQ:MRNA) Estimates After Its First-Quarter Results
Simply Wall St. via Yahoo Finance· 3 days agoModerna, Inc. (NASDAQ:MRNA) just released its quarterly report and things are looking bullish....